ʻO LL-37 kahi peptide antimicrobial mai ka cathelicidin ʻohana. ʻO ka inoa pono'ī e pili ana i kona 37 ka hui ʻana o ka amino acid a me ka hoʻomaka N-terminal o ʻelua leucine koena. HCAP18, ka lālā hoʻokahi o ka ʻohana cathelicidin kanaka, ua hoʻokaʻawale ʻia e nā protease kanaka e hoʻokuʻu i kēia ʻāpana LL-37 biologically active..
ʻO ka loaʻa ʻana o LL-37 i hōʻailona i ka hoʻololi maʻamau o ka noiʻi cathelicidin mai nā hiʻohiʻona holoholona i nā kānaka.. Ma ke ʻano he mea koʻikoʻi o ka ʻōnaehana immune innate, He kuleana koʻikoʻi ka LL-37 i ka pale ʻana i ke kanaka mai nā pathogens.
ʻO ka hana nui o kēia pale ʻo ia ka hana antibacterial pololei ākea ākea. ʻO ka amphipathic α-helical(Alpha helix) ʻO ka hoʻolālā e pili ana i kēia hana e hoʻoulu i ka huki electrostatic i nā membrane bacteria i hoʻopiʻi maikaʻi ʻia. ʻO ka hoʻohaunaele pololei i ka pono o ka membrane e alakaʻi i ka nalowale o nā meaʻai intracellular; make bacteria piha. ʻIke ʻia, ʻAʻole hoʻokomo kēia mīkini i kekahi ʻano kūʻē.
Hoʻopili ʻia nā hana ʻē aʻe i loko o ke kino – hoʻōla ʻeha, hoʻoponopono kino, immunomodulation ikaika, endotoxin hoʻopaʻapaʻa, a hōʻike i nā hopena anti-cancer a me nā anti-viral.
Kaʻina
Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-As-As
Helu CAS
154947-66-7
ʻĀpana Molekala
C205H340N60O53
Kaumaha Molekala
4493.34
LL-37 noiʻi pili
1.Nā Hana Antibacterial Direct Spectrum
ʻO ka hana bactericidal wikiwiki a pololei i nā ʻano like ʻole microorganisms ʻO LL-37 ka hana i kākau maikaʻi ʻia. Gram ʻinoʻino, maikaʻi, a me kekahi fungal nā pathogens pau loa i ka pepehiia.
ʻO ka cationic, ʻO nā hiʻohiʻona amphipathic o ka peptide ke kī i kēia kaʻina hana; paʻa pololei nā ʻāpana i hoʻopaʻa ʻia i nā membrane bacteria. ʻO ka leaka ʻana o nā mea kelepona a me ka hāʻule ʻana o ka hikina membrane ka hopena hope o ka hoʻouka ʻana.
Hana nā lāʻau antibiotic maʻamau i nā ʻano like ʻole (a pinepine i ka pahu hopu) nā ala kūʻē; ʻO ke ʻano o ka hoʻouka ʻana o LL-37 he wikiwiki a, i kēia lā, ʻaʻole pili me ka hoʻomohala kūʻē nui. Kākoʻo nā haʻawina lāʻau kanaka i ka palekana a me ka pono o LL-37 ma ke ʻano he mea lapaʻau.
2.Hana Immunomodulatory ikaika
Hoʻohana ʻo LL-37 i kona hopena ma muli o ka microenvironment kūloko i loko o ke kino. I ka ʻike ʻana i ka ʻeha o ka ʻiʻo a i ʻole nā loli pathological, Hoʻoulu ʻo LL-37 i nā mea hoʻoponopono like ʻole a me nā cell e hōʻuluʻulu i kēia mau pūnaewele.
ʻO ka modulation o ka hoʻokuʻu cytokine inflammatory kekahi o kāna mau ala mua; hoʻohaʻahaʻa pono ʻia nā pane pro-inflammatory nui loa. Hoʻolaha cell dendritic(DC) oo ana a mahope T cell ʻO ka ʻokoʻa kekahi mea nui o kēia kaʻina hana – e hōʻike ana i kahi alahaka koʻikoʻi ma waena o ka palekana kūlohelohe a me ka adaptive.
3.Hoʻoikaika i ka hoʻōla ʻana i ka ʻeha a me ka hoʻoponopono ʻana i ka ʻili
Hoʻopili pololei ʻia ka ho'ōla ʻeha o LL-37 a me ka hiki ke hoʻoponopono i ka ʻiʻo i kāna mau hana immunomodulatory., me ka hana antimicrobial pololei.
Hoʻoulu ʻia nā ala antimicrobial keratinocytes, fibroblasts, a me nā pūnaewele endothelial e neʻe aku i ka wahi ʻeha; ʻo ka hoʻonui ʻana o nā cell i ka wā e hoʻoponopono ʻia ai ka pōʻino. Hāʻawi ka Angiogenesis i ka ikehu a me ka hāʻawi ʻana i nā meaʻai i ka ʻiʻo ʻeha.
4.Hana kūʻē i ke kanesa
Hoʻokaʻawale nā pūnaewele maʻi maʻi i ke ʻano maʻamau o ka hōʻike ʻana i nā hoʻopiʻi ʻino phosphatidylserine ma ko lakou mau membrane waho (nā pūnaewele maʻamau i loaʻa i loko o kēia mau mea phospholipids). ʻO ka hoʻopiʻi maikaʻi o LL-37 no laila ua huki ʻia iā lākou.
Hoʻomaka ʻia nā ala make apoptosis a me necrotic e like me nā mea i hoʻohana ʻia e kūʻē i ka bacteria. ʻAʻole pololei anti-tumor pāʻani pū kekahi i nā hopena ma o ka modulation immune.
Ua hōʻike nā haʻawina preclinical i ka hōʻemi maopopo ʻana o nā maʻi maʻi maʻi i mālama ʻia me LL-37; ʻO ka lāʻau anticancer e hoʻohana ana i ka LL-37 kahi wahi hoʻohiki o ka noiʻi.
COA
HPLC
MS





